LABT

Lakewood-Amedex Biotherapeutics Inc.

Nasdaq· Pharmaceutical Preparations· Inc. NV· CIK 0002079272 Biotech & Drug Discovery

$0.2699 −0.04 (−12.94%)

Oct 26 4:00 PM ET · prev $0.3100

Market cap

$1.2M

Nano cap

Median target

$12.00

+4346% · range $12.00–12.00

Since first trade

−99.7%

from $86.50 · Apr 23

30 days

−76.5%

from $1.15

Range since listing

$0.2699–86.50

at the low

Avg volume 20D

2.73M

Oct 23 spike 39.46M

Short interest

130.7K

≈5.5% of shares · +146.8%

Days to cover

1.0

at average volume

Insider net

no open-market trades · 12 mo

Reddit crowd

50°

Neutral · 1 mention this week

Filing reports

analyzed by SecBot

SecBot read MIXED 2 reports · 90 days

Balance 1 bearish · 1 bullish oldest → newest, height = score

Avg score

·High conf. 1/2

Strongest BULLISH The SEC declared effective a registration statement (File No. 333-299027) for Lakewood-Amedex…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

X Jul 15 Short interest falls 36.4% to 24.0K
X Jul 31 Short interest jumps 424.7% to 126.1K
X Aug 14 Short interest falls 55.4% to 56.3K
R Sep 25 The SEC declared effective a registration statement (File No. 333-29…
X Sep 30 Short interest jumps 146.8% to 130.7K

Signal stack

Where each data set points today.

InsidersNO TRADES

No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
EstimatesFALLING

Current-quarter EPS estimate −$0.560 → −$0.810 over 90 days. 0 up, 1 down in 30 days.
Short sellersBUILDING

Short interest +146.8% to 130.7K shares. 1.0 days to cover, ≈5.5% of shares.
TrendDOWNTREND

83% below its 50-day average. New closing low $0.2699 on Oct 26.
SocialQUIET

Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup call.

Who's buying

13F

Top holder	Shares	Value
Marex Group Ltd	48,167	$151.2K
HRT FINANCIAL LP	44,782	$140.0K
UBS Group AG	4,098	$12.9K
OSAIC HOLDINGS, INC.	138	$433.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12-month targets · 1 analysts

$0.2699 $12.00 $12.00 $12.00

Price is below the lowest target. Median implies +4346%.Targets as of Oct 26, 2026.

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Recent

May 6, 2026

Short interest

FTD: LABT — 197,777 shares ($0.6M) failed to deliver

Settlement: 20260506, Price: $3.10, FTD Value: $613,108.7, LAKEWOOD-AMEDEX BIOTHERAPEUTIC

May 5, 2026

Short interest

FTD: LABT — 348,096 shares ($1.1M) failed to deliver

Settlement: 20260505, Price: $3.26, FTD Value: $1,134,792.96, LAKEWOOD-AMEDEX BIOTHERAPEUTIC

May 4, 2026

Short interest

FTD: LABT — 787,788 shares ($2.7M) failed to deliver

Settlement: 20260504, Price: $3.43, FTD Value: $2,702,112.84, LAKEWOOD-AMEDEX BIOTHERAPEUTIC

Apr 29, 2026

Short interest

FTD: LABT — 184,360 shares ($0.7M) failed to deliver

Settlement: 20260429, Price: $3.89, FTD Value: $717,160.4, LAKEWOOD-AMEDEX BIOTHERAPEUTIC

Apr 28, 2026

Short interest

FTD: LABT — 254,934 shares ($0.9M) failed to deliver

Settlement: 20260428, Price: $3.66, FTD Value: $933,058.44, LAKEWOOD-AMEDEX BIOTHERAPEUTIC

Insider ledger

Form 4

open-market buys or sells · 12 mo

Date	Insider	Type	Value
Apr 24, 2026	Tucker Joseph Edward Director	AWARD	33,784 sh

Earnings setup

Estimates

−$0.81

EPS estimate, this quarter

−45%

estimate change, 90 days

0↑ 1↓

revisions, 30 days

Current-quarter EPS estimate

−$0.560

90d

−$0.560

60d

−$0.810

30d

−$0.810

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.81	-$0.81–-$0.81	+0.0%	$0.00
Next Q	-$0.76	-$0.76–-$0.76	+0.0%	$0.00
Current FY	-$4.96	-$4.96–-$4.96	+0.0%	$0.00
Next FY	-$1.32	-$1.32–-$1.32	+0.0%	$0.00